News
MedPage Today on MSN6d
Soap Recall Over Sepsis Risk; FDA Rehires Vinay Prasad; NIH Reports Patient to ICE
DermaRite Industries is recalling certain lots of its over-the-counter soaps, antiseptics, and analgesics due to ...
BACK TO CBER — Dr. Vinay Prasad has returned to the FDA’s Center for Biologics Evaluation and Research, leaving industry and ...
HealthDay on MSN3d
Vinay Prasad Returns to FDA After Being Ousted
Dr Vinay Prasad will return to head the FDA’s Center for Biologics Evaluation and Research less than 2 weeks after being ousted.
Robert F. Kennedy’s right-hand man was briefly Laura Loomer’s latest scalp, but had his job saved thanks to the intervention ...
5dOpinion
Drug Approvals Hit an FDA Wall
Therapies for rare and deadly disease are dying in Marty Makary’s shop.
No matter what regulatory decisions Dr. Vinay Prasad makes moving forward, the fact that he was willing to legitimize and ...
Vinay Prasad was reinstated as the head of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA) on 11 August. He had resigned on 29 July.1 “At the FDA’s ...
A Food and Drug Administration official is getting his job back as the agency’s top vaccine regulator, less than two weeks ...
Nonetheless, Kennedy is still in charge of the entire department, and it is likely only a matter of time until he resumes ...
Sarepta Therapeutics has provided additional safety data on its gene therapy Elevidys as a Duchenne muscular dystrophy ...
A well-connected drug company and Laura Loomer wanted Kennedy ally Vinay Prasad gone. Trump chief of staff Susie Wiles got ...
A handful of drug companies have formed a group to present lawmakers with research on the negative impacts of Medicare drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback